Open Government Canada
Priority Review of Drug Submissions (Therapeutic Products)
Published by Health Canada | Santé Canada
About this dataset
Priority Review is a fast-track status granted to eligible new drug submissions for human use, following review and approval of a request submitted by the sponsor of the drug. Priority Review submissions are introduced into Health Canada's drug review queue in accordance with an accelerated review target of 180 days.